The DUPIXENT MyWay Patient Assistance Program is a separate savings option for patients who do not qualify for the copay card including those without commercial insurance, those on Medicare or Medicaid, or those experiencing difficulty paying for treatment
Common adverse effects (percent incidence) Serious risks include pancreatitis, gallbladder issues, and thyroid C-cell tumors (boxed warning for both)
Side effects typically stabilize as your body adjusts
They may carry an increased risk in the right setting, including concerns related to thyroid tumors, gallbladder disease, pancreatitis, and low blood sugar when used with certain other diabetes medications
Navigating the Costs and Insurance Landscape Affordability and insurance coverage are critical factors when it comes to GLP-1 agonists
The product may be degraded before it ever reaches the nasal epithelium